Search research articles
Contact Us
Filters
Showing results (531-540 of 570) with videos related to
Page
of 57
Sort By:
Cancer Discovery
|
January 18, 2014
Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors
Jack F Shern, Li Chen, Juliann Chmielecki, et al.
JCO Precision Oncology
|
June 7, 2021
Pathogenic Germline Variants in Cancer Susceptibility Genes in Children and Young Adults With Rhabdomyosarcoma
Jung Kim, Nicholas Light, Vallijah Subasri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 20, 2023
National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH)
Funda Meric-Bernstam, James M Ford, Peter J O'Dwyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 4, 2023
Combination Early-Phase Trials of Anticancer Agents in Children and Adolescents
Lucas Moreno, Steven G DuBois, Julia Glade Bender, et al.
HGG Advances
|
June 11, 2025
The Impact of Genetic Ancestry on Survival Outcomes in Pediatric Rhabdomyosarcoma: A Report from the Children's Oncology Group
Ekene A Onwuka, Christina L Magyar, Bailey A Martin-Giacalone, et al.
Cancer Discovery
|
September 30, 2018
Genome-Informed Targeted Therapy for Osteosarcoma
Leanne C Sayles, Marcus R Breese, Amanda L Koehne, et al.
The Oncologist
|
June 14, 2024
Phase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm G
Marie V Nelson, AeRang Kim, P Mickey Williams, et al.
Journal of the National Cancer Institute
|
March 23, 2023
Germline genetic variants and pediatric rhabdomyosarcoma outcomes: a report from the Children's Oncology Group
Bailey A Martin-Giacalone, Melissa A Richard, Michael E Scheurer, et al.
Journal of the National Cancer Institute
|
June 14, 2025
Enrollment in children's oncology group's clinical trials: population-based linkage with the national childhood cancer registry
Philip J Lupo, David A Siegel, Nicola C Schussler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 8, 2022
Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
David Milewski, Hyun Jung, G Thomas Brown, et al.
Page
of 57
Search research articles
Search
Showing results (531-540 of 570) with videos related to
Sort By:
Page
of 57
Cancer Discovery
|
January 18, 2014
Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors
Jack F Shern, Li Chen, Juliann Chmielecki, et al.
JCO Precision Oncology
|
June 7, 2021
Pathogenic Germline Variants in Cancer Susceptibility Genes in Children and Young Adults With Rhabdomyosarcoma
Jung Kim, Nicholas Light, Vallijah Subasri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 20, 2023
National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH)
Funda Meric-Bernstam, James M Ford, Peter J O'Dwyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 4, 2023
Combination Early-Phase Trials of Anticancer Agents in Children and Adolescents
Lucas Moreno, Steven G DuBois, Julia Glade Bender, et al.
HGG Advances
|
June 11, 2025
The Impact of Genetic Ancestry on Survival Outcomes in Pediatric Rhabdomyosarcoma: A Report from the Children's Oncology Group
Ekene A Onwuka, Christina L Magyar, Bailey A Martin-Giacalone, et al.
Cancer Discovery
|
September 30, 2018
Genome-Informed Targeted Therapy for Osteosarcoma
Leanne C Sayles, Marcus R Breese, Amanda L Koehne, et al.
The Oncologist
|
June 14, 2024
Phase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm G
Marie V Nelson, AeRang Kim, P Mickey Williams, et al.
Journal of the National Cancer Institute
|
March 23, 2023
Germline genetic variants and pediatric rhabdomyosarcoma outcomes: a report from the Children's Oncology Group
Bailey A Martin-Giacalone, Melissa A Richard, Michael E Scheurer, et al.
Journal of the National Cancer Institute
|
June 14, 2025
Enrollment in children's oncology group's clinical trials: population-based linkage with the national childhood cancer registry
Philip J Lupo, David A Siegel, Nicola C Schussler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 8, 2022
Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
David Milewski, Hyun Jung, G Thomas Brown, et al.
Page
of 57